Related Experiment Video

Updated: May 12, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics

Brian R Rood1, Dominique Leprince

  • 1Center for Cancer and Blood Disorders, Children's National Medical Center, Division of Oncology, 111 Michigan Ave. NW, Washington, DC 20010, USA.

Expert Opinion on Therapeutic Targets
|April 10, 2013
PubMed
Abstract

Insights

The tumor suppressor gene Hypermethylated in Cancer 1 (HIC1) is epigenetically silenced in tumors, impacting cell growth and migration. Understanding HIC1

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Epigenetics

Background:

  • The tumor suppressor gene Hypermethylated in Cancer 1 (HIC1) is epigenetically silenced, not mutated, in various tumors.
  • HIC1 plays crucial roles in normal development and is involved in cancer-related processes like cell growth, survival, migration, and motility.

Purpose of the Study:

  • To review the literature on HIC1, including its discovery, function as a tumor suppressor, mechanism of action, target genes, and role in tumorigenesis.
  • To explore the implications of HIC1 loss of function in the early stages of cancer development.

Main Methods:

  • Literature review of HIC1's discovery, tumor suppressor roles, and molecular mechanisms.
  • Analysis of HIC1's function as a sequence-specific transcriptional repressor and its recruitment of chromatin regulatory complexes.
  • Examination of HIC1's target genes and their involvement in cellular processes.

Main Results:

  • HIC1 acts as a sequence-specific transcriptional repressor, recruiting chromatin regulatory complexes.
  • Loss of HIC1 function contributes to the early steps of tumorigenesis.
  • HIC1's targets and their regulatory roles are critical for understanding its tumor suppressor activity.

Conclusions:

  • HIC1's loss leads to specific alterations in the cell's transcriptional program.
  • Identifying HIC1 target genes and their regulatory roles is key to therapeutic translation.
  • Understanding HIC1's impact on cellular processes offers potential for novel cancer therapies.

More Related Videos

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...